Royal Bank of Canada
CARM

Royal Bank of Canada’s Carisma Therapeutics CARM Stock Holding History

Royal Bank of Canada’s Portfolio CARM Stock Details CARM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-32
Closed – – 7193
2025
Q3 		$0 Buy
+32
New +$11 ﹤0.01% 7154
2024
Q3 		– Sell
-104
Closed – – 6894
2024
Q2 		$0 Sell
104
-914
-90% -$1.36K ﹤0.01% 7082
2024
Q1 		$2K Sell
1,018
-7,473
-88% -$18K ﹤0.01% 6651
2023
Q4 		$25K Buy
8,491
+4,014
+90% +$11.9K ﹤0.01% 6239
2023
Q3 		$19K Buy
4,477
+1,696
+61% +$10.7K ﹤0.01% 6192
2023
Q2 		$24K Buy
2,781
+2,616
+1,585% +$14.2K ﹤0.01% 6111
2023
Q1 		$1K Buy
165
+144
+686% +$1.37K ﹤0.01% 6864
2022
Q4 		$0 Sell
21
-33
-61% -$347 ﹤0.01% 7253
2022
Q3 		$0 Buy
54
+39
+260% +$531 ﹤0.01% 7467
2022
Q2 		$0 Sell
15
-688
-98% -$7.87K ﹤0.01% 7389
2022
Q1 		$8K Sell
703
-1,633
-70% -$22.8K ﹤0.01% 7041
2021
Q4 		$38K Buy
2,336
+1,215
+108% +$24.5K ﹤0.01% 6522
2021
Q3 		$17K Buy
1,121
+529
+89% +$25.4K ﹤0.01% 6763
2021
Q2 		$55K Buy
592
+586
+9,767% +$37.4K ﹤0.01% 5968
2021
Q1 		$0 Buy
+6
New +$283 ﹤0.01% 7437
2020
Q4 		– Sell
-68
Closed -$1.72K – 7072
2020
Q3 		$2K Sell
68
-108
-61% -$2.16K ﹤0.01% 6302
2020
Q2 		$2K Buy
176
+15
+9% +$202 ﹤0.01% 6269
2020
Q1 		$2K Buy
161
+97
+152% +$1.59K ﹤0.01% 6275
2019
Q4 		$2K Sell
64
-7
-10% -$161 ﹤0.01% 6544
2019
Q3 		$2K Buy
71
+46
+184% +$1.08K ﹤0.01% 6269
2019
Q2 		$1K Hold
25
– – ﹤0.01% 6679
2019
Q1 		$1K Hold
25
– – ﹤0.01% 6621
2018
Q4 		$1K Sell
25
-252
-91% -$8.04K ﹤0.01% 6548
2018
Q3 		$12K Buy
277
+252
+1,008% +$9.82K ﹤0.01% 5901
2018
Q2 		$1K Sell
25
-1
-4% -$44 ﹤0.01% 6335
2018
Q1 		$1K Buy
26
+1
+4% +$19 ﹤0.01% 6186
2017
Q4 		$0 Hold
25
– – ﹤0.01% 6550
2017
Q3 		$1K Hold
25
– – ﹤0.01% 6611
2017
Q2 		$1K Hold
25
– – ﹤0.01% 6369
2017
Q1 		$1K Hold
25
– – ﹤0.01% 6499
2016
Q4 		$1K Hold
25
– – ﹤0.01% 6542
2016
Q3 		$1K Hold
25
– – ﹤0.01% 6263
2016
Q2 		$1K Hold
25
– – ﹤0.01% 6228
2016
Q1 		$0 Sell
25
-5
-17% -$69 ﹤0.01% 6361
2015
Q4 		$2K Buy
30
+25
+500% +$1.42K ﹤0.01% 6351
2015
Q3 		$0 Sell
5
-10
-67% -$616 ﹤0.01% 6639
2015
Q2 		$1K Buy
15
+14
+1,400% +$1.98K ﹤0.01% 6430
2015
Q1 		$0 Buy
+1
New +$218 ﹤0.01% 6140

Other funds holding CARM

MC
Merck & Co Kenilworth, New Jersey $526M AUM 175.27% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
EF
Empowered Funds Havertown, Pennsylvania $15.7B AUM 34.02% 1-Year Est. Return
BBA
Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return
UBP
Union Bancaire Privee Geneva 1, Switzerland $9.16B AUM 31.4% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
OP
ORG Partners Roanoke, Indiana $568M AUM 24.16% 1-Year Est. Return

Royal Bank of Canada's CARM Position: Q4 2025 in Review

Royal Bank of Canada sold out of Carisma Therapeutics (CARM) in Q4 2025, closing a stake of 32 shares.

Royal Bank of Canada first reported a position in CARM in Q1 2015 and held it in 38 quarters. The position peaked at $55K in Q2 2021. 7 funds tracked by Wall St. Rank hold CARM as of Q4 2025.

  • Royal Bank of Canada reported no remaining Carisma Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Royal Bank of Canada sold 32 Carisma Therapeutics shares in Q4 2025.
  • Royal Bank of Canada first reported a position in Carisma Therapeutics in Q1 2015 and held it in 38 quarters.
  • Royal Bank of Canada's Carisma Therapeutics position peaked at $55K in Q2 2021.
  • 7 funds tracked by Wall St. Rank held Carisma Therapeutics as of Q4 2025.

Based on Royal Bank of Canada's 13F filing for Q4 2025, filed 17 Feb 2026.